ASP Isotopes Inc. Common Stock
NASDAQ:ASPIChemicals
+$0.32 today
- Market cap
- $191.68M
- Beta
- 3.44
- P/E (TTM)
- -4.9
- EPS (TTM)
- -$1.43
Volume 7.05M
Average 5.68M
ASPI Depreciation & Amortization
Non-cash expense that spreads the cost of physical and intangible assets over their useful lives.
ASP Isotopes Inc. Common StockNASDAQ: ASPI
Depreciation & Amortization · Q1 FY2026 · quarter ended Mar 2026
Depreciation & amortization growth accelerates
Q1 FY2026 depreciation & amortization of $3.06M rose 1951.6% year over year, ahead of the +831.9% change in trailing-twelve-month depreciation & amortization. Sequentially, it rose 226.3% from the prior quarter. Over 3 fiscal years it compounded at +197.6% a year.
Context
- Depreciation & amortization amounted to 8.0% of revenue in FY2025, down 3.3 pp from a year earlier.
- Depreciation & amortization increased in 2 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth of +1951.6% holds above the trailing-twelve-month pace of +831.9%.
Sources:Income StatementText generated from reported figures; not investment advice.
Depreciation & Amortization history
USD · from the income statement
- Latest · FY2025
- 1.91M USD
- Year-over-year change
- +305.9%
- 4-year CAGR
- +215.2%
| Period | Period end | Depreciation & Amortization | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 1.91M | +305.9% |
| FY2024 | 2024-12-31 | 471K | +1158.2% |
| FY2023 | 2023-12-31 | 37.43K | -48.4% |
| FY2022 | 2022-12-31 | 72.57K | +274.5% |
| FY2021 | 2021-12-31 | 19.38K | — |
Depreciation & Amortization vs competitors
How ASPI compares with its peers on the latest reported figures
- Peers report in different currencies, so depreciation & amortization is compared through growth and share of revenue rather than absolute size.
- Its year-over-year change of +831.9% is the highest of 11, against a peer median of +6.6%.
- Depreciation & amortization amounts to 17.9% of revenue for ASPI, versus a peer median of 5.8%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | R$5.14B BRL | +11.5% | -1.1% | 7.7% | |
| LTM Mar 2026 | $322M USD | +7.3% | +4.8% | 11.0% | |
| LTM Mar 2026 | $129.77M USD | +14.0% | +10.0% | 5.5% | |
| LTM Mar 2026 | $106.17M USD | +13.4% | +1.9% | 8.6% | |
| LTM Mar 2026 | $104.5M USD | -1.4% | -2.9% | 8.1% | |
| LTM Mar 2026 | $99.68M USD | +4.9% | +2.0% | 5.1% | |
| LTM Mar 2026 | $84.03M USD | +13.1% | +1.4% | 6.1% | |
| LTM Apr 2026 | $23.03M USD | +4.4% | +17.8% | 4.7% | |
| LTM Mar 2026 | $4.82M USD | +831.9% | +197.6% | 17.9% | |
| LTM Mar 2026 | $4.52M USD | +5.9% | -15.1% | 3.4% | |
| LTM Mar 2026 | $1.33M USD | +5.2% | +11.0% | 3.4% | |
| Peer median (excluding ASPI) | — | +6.6% | +1.9% | 5.8% | |
Competitors are the stored peer set for ASPI. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 433.03K | 4.14M | 23.85M |
| Cost of Revenue | 19.38K | 0 | 294.06K | 2.55M | 20.44M |
| Gross Profit | (19.38K) | 0 | 138.97K | 1.6M | 3.41M |
| Gross Margin | — | — | 32.1% | 38.6% | 14.3% |
| Research & Development | 41.61K | 1.27M | 764.58K | 3.14M | 12.36M |
| Selling, General & Admin | 2.55M | 3.83M | 15.42M | 24.81M | 48.24M |
| Operating Expenses | 2.59M | 5.1M | 16.18M | 27.95M | 60.6M |
| Depreciation & Amortization | 19.38K | 72.57K | 37.43K | 471K | 1.91M |
| EBITDA | (2.59M) | (4.87M) | (16.14M) | (31.58M) | (157.07M) |
| EBITDA Margin | — | — | -3728.2% | -762.1% | -658.6% |
| Operating Income | (2.61M) | (5.1M) | (16.04M) | (26.35M) | (57.19M) |
| Operating Margin | — | — | -3704.6% | -636.0% | -239.8% |
| Interest Income | 115 | 3.38K | 9.07K | 1.24M | 6.79M |
| Interest Expense | 0 | 0 | 118.55K | 258.87K | 575K |
| Other Income / Expenses | 113 | 153.91K | (258.26K) | (5.96M) | (102.37M) |
| Income Before Tax | (2.61M) | (4.95M) | (16.3M) | (32.31M) | (159.56M) |
| Pre-Tax Margin | — | — | -3764.3% | -779.7% | -669.0% |
| Income Tax Expense | 0 | 0 | (6.13K) | 111.45K | 282K |
| Net Income | (2.61M) | (4.95M) | (16.29M) | (32.33M) | (175.09M) |
| Net Margin | — | — | -3761.0% | -780.3% | -734.2% |
| EPS (Basic) | (0.08) | (0.13) | (0.49) | (0.63) | (2.11) |
| EPS (Diluted) | (0.08) | (0.13) | (0.49) | (0.63) | (2.11) |
| Weighted Avg Shares | 34.36M | 35.91M | 33.07M | 55.67M | 83.01M |
| Weighted Avg Shares (Diluted) | 34.36M | 35.91M | 33.07M | 55.67M | 83.01M |
ASP Isotopes Inc. Common Stock
NASDAQ:ASPI
Intrinsic Alpha fair value
Locked
Current Price
$1.23
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.